Viktorija O Barr
Overview
Explore the profile of Viktorija O Barr including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
10
Citations
120
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
ODonnell J, Rhodes N, Miglis C, Zembower T, Qi C, Hoff B, et al.
Int J Antimicrob Agents
. 2021 Dec;
59(2):106490.
PMID: 34871745
Background: Antimicrobial stewardship intervention (ASI) appears to be necessary to realize the full benefits of rapid diagnostic technologies in clinical practice. This study aimed to compare clinical outcomes between early...
2.
Gilbert E, Rhodes N, McLaughlin M, Cottreau J, Scheetz M, Postelnick M, et al.
J Pharm Technol
. 2021 Dec;
33(4):146-150.
PMID: 34860990
An on call infectious diseases (ID) pharmacist may be used as a resource for physicians, pharmacists, and other health care providers to help answer questions regarding anti-infective agents. To assess...
3.
Diagnostic stewardship of C. difficile testing: a quasi-experimental antimicrobial stewardship study
Christensen A, Barr V, Martin D, Anderson M, Gibson A, Hoff B, et al.
Infect Control Hosp Epidemiol
. 2019 Feb;
40(3):269-275.
PMID: 30786942
Objective: We evaluated whether a diagnostic stewardship initiative consisting of ASP preauthorization paired with education could reduce false-positive hospital-onset (HO) Clostridioides difficile infection (CDI). Design: Single center, quasi-experimental study. Setting:...
4.
Shaw B, Masic I, Gorgi N, Kalfayan N, Gilbert E, Barr V, et al.
J Pharm Pract
. 2018 Sep;
33(3):243-246.
PMID: 30180773
Background: Many patients with a self-reported penicillin allergy go on to tolerate beta-lactam antibiotics. Allergy specialists may be consulted to determine the nature and extent of the allergy. However, electronic...
5.
McLaughlin M, Galal A, Richardson C, Sutton S, Barr V, Patel N, et al.
Transpl Infect Dis
. 2017 Aug;
19(6).
PMID: 28833985
Kidney transplant recipients who are switched to atovaquone (ATO) from trimethoprim-sulfamethoxazole (TMP/SMX) for Pneumocystis jirovecii pneumonia (PJP) prophylaxis because of adverse events or complications may miss opportunities to be re-challenged...
6.
Krapp F, Grant J, Sutton S, Ozer E, Barr V
Int J Antimicrob Agents
. 2017 Apr;
49(6):770-773.
PMID: 28389354
Ceftazidime/avibactam (CAZ/AVI) is the first antimicrobial agent with activity against carbapenem-resistant Enterobacteriaceae (CRE) approved by the US Food and Drug Administration (FDA). Notably, human clinical outcome data for this indication...
7.
Lee B, Rao S, Wang S, Lee J, Lakada I, Gilbert E, et al.
Int J Antimicrob Agents
. 2017 Mar;
49(5):650-654.
PMID: 28279787
Methicillin-susceptible Staphylococcus aureus (MSSA) infections have been successfully treated both with cefazolin and antistaphylococcal penicillins; cefazolin appears effective in MSSA bloodstream infections (BSIs). Thus, our antimicrobial stewardship programme (ASP) implemented...
8.
Cottreau J, Barr V
Pharmacotherapy
. 2016 May;
36(6):668-78.
PMID: 27139037
Antiviral and antifungal use in pregnancy presents challenges because of the paucity of clinical and safety data for many agents in these classes. If untreated, viral and fungal infections can...
9.
Casapao A, Davis S, Barr V, Klinker K, Goff D, Barber K, et al.
Antimicrob Agents Chemother
. 2014 Feb;
58(5):2541-6.
PMID: 24550331
Ceftaroline has been approved for acute bacterial skin infections and community-acquired bacterial pneumonia. Limited clinical experience exists for use outside these indications. The objective of this study was to describe...
10.
Pogue J, Mynatt R, Marchaim D, Zhao J, Barr V, Moshos J, et al.
Infect Control Hosp Epidemiol
. 2014 Jan;
35(2):132-8.
PMID: 24442074
Objective: To assess the impact of active alerting of positive blood culture data coupled with stewardship intervention on time to appropriate therapy, length of stay, and mortality in patients with...